Australia, under lockdown, sees jump in COVID-19 cases
SYDNEY-Reuters
![Australia, under lockdown, sees jump in COVID-19 cases](http://image.hurimg.com/i/hurriyet/75/0x0/60f7c5f74e3fe00e3ce76c13.jpg)
Australia's two largest states reported sharp increases in new COVID-19 cases on July 21, a blow to hopes that lockdown restrictions would be lifted with more than half the country's population under stay-at-home orders.
New South Wales (NSW) state, home to the country's most populous city Sydney, logged 110 new cases, up from 78 the day before, nearly four weeks into a lockdown of the city and surrounding areas to contain an outbreak of the virulent Delta variant.
Victoria state clocked 22 new cases, from nine the day before, its biggest increase since the outbreak began this month, as it nears its second week of statewide lockdown.
"Had we not gone into the lockdown a few weeks ago, the 110 number today would undoubtedly have been thousands and thousands," said NSW Premier Gladys Berejiklian at a televised news conference.
"But we need to work harder and, of course, all of us need to be on guard," she added.
Health leaders have said their greatest concern is the number of people active in the community before receiving their coronavirus diagnosis, and that the number should be near zero before lifting lockdown.
Berejiklian said that number jumped to 43 on July 21, double the previous day, and that she could not say until the following week whether the city would exit lockdown by a July 30 target.
Overnight, NSW added three regional centres some 250 km (150 miles) from Sydney to the list of areas under lockdown after a pet food delivery driver tested positive there, raising fears of local transmission.
"We know every day who's going to walk though the door, but even the locals that do come in, they're buying for like four days, rather than buying for every single day," said Cameron Cassel, a butcher in Blayney, population 3,000. Victorian authorities, meanwhile, said 16 of its 22 new cases were in quarantine during their infectious period, while exposure sites for the remaining six were "reasonably low".
"That is something that should give us all a degree of confidence and hope that this response... is working," said Victorian Health Minister Martin Foley.
A third state, South Australia, went into its first full day of a week-long lockdown on July 21, and reported one additional case.
'More Pfizer'
A year and a half into the pandemic, some 13 million Australians are under hard lockdown, raising pressure on the federal government which has seen its polling at its lowest in a year due to a sluggish immunisation program. Just over 11% of the population is fully vaccinated.
The main vaccine in the government's arsenal, developed by AstraZeneca Plc, has been recommended for use only for people aged over 60 due to a remote risk of blood clotting, while a vaccine made by Pfizer Inc has been restricted to over-40s due to limited supply.
Under mounting pressure, Prime Minister Scott Morrison said on July 21 his government has asked its independent expert panel, the Australian Technical Advisory Group on Immunisation, to relax its advice on the use of the AstraZeneca vaccine.
"It's for them to now constantly reconsider how that balance of risk applies and provide their advice accordingly," Morrison told reporters in Canberra.
While the sluggish vaccine roll-out has frustrated voters, the introduction of shutdowns has also taken a toll on Australia's A$2 trillion ($1.5 trillion) economy, which had roared back to pre-pandemic levels after the initial upheaval of early 2020.
Data published on July 21 showed retail sales in June slumped 1.8% from a month earlier, nearly four times the drop foreshadowed by economists.
Morrison also said there would be a "significant impact" on GDP figures that will be published in early September, although he said advice from Australia's central bank suggested the toll would be mitigated in the following quarter.
Australia has fared better than many other developed economies in keeping COVID-19 numbers relatively low, with just over 32,100 cases and 915 deaths.